• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1 基因-675 4G/5G 多态性与哮喘风险相关:一项荟萃分析。

The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.

机构信息

Department of Respiratory Disease, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.

出版信息

PLoS One. 2012;7(3):e34385. doi: 10.1371/journal.pone.0034385. Epub 2012 Mar 27.

DOI:10.1371/journal.pone.0034385
PMID:22479620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3313978/
Abstract

BACKGROUND

A number of studies assessed the association of -675 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor (PAI)-1 gene with asthma in different populations. However, most studies reported inconclusive results. A meta-analysis was conducted to investigate the association between polymorphism in the PAI-1 gene and asthma susceptibility.

METHODS

Databases including Pubmed, EMBASE, HuGE Literature Finder, Wanfang Database, China National Knowledge Infrastructure (CNKI) and Weipu Database were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association in the dominant model, recessive model, codominant model, and additive model.

RESULTS

Eight studies involving 1817 cases and 2327 controls were included. Overall, significant association between 4G/5G polymorphism and asthma susceptibility was observed for 4G4G+4G5G vs. 5G5G (OR = 1.56, 95% CI 1.12-2.18, P = 0.008), 4G/4G vs. 4G/5G+5G/5G (OR = 1.38, 95% CI 1.06-1.80, P = 0.02), 4G/4G vs. 5G/5G (OR = 1.80, 95% CI 1.17-2.76, P = 0.007), 4G/5G vs. 5G/5G (OR = 1.40, 95% CI 1.07-1.84, P = 0.02), and 4G vs. 5G (OR = 1.35, 95% CI 1.08-1.68, P = 0.008).

CONCLUSIONS

This meta-analysis suggested that the -675 4G/5G polymorphism of PAI-1 gene was a risk factor of asthma.

摘要

背景

许多研究评估了纤溶酶原激活物抑制剂(PAI-1)基因启动子区域的-675 4G/5G 多态性与不同人群哮喘之间的关联。然而,大多数研究的结果并不一致。进行了一项荟萃分析,以研究 PAI-1 基因多态性与哮喘易感性之间的关系。

方法

检索了 Pubmed、EMBASE、HuGE Literature Finder、万方数据库、中国知网(CNKI)和维普数据库等数据库,以寻找相关研究。使用优势模型、隐性模型、共显性模型和加性模型的优势比(OR)和 95%置信区间(CI)来评估关联的强度。

结果

共纳入 8 项研究,包括 1817 例病例和 2327 例对照。总体而言,4G/5G 多态性与哮喘易感性之间存在显著关联,4G4G+4G5G 与 5G5G 相比(OR=1.56,95%CI 1.12-2.18,P=0.008),4G/4G 与 4G/5G+5G/5G 相比(OR=1.38,95%CI 1.06-1.80,P=0.02),4G/4G 与 5G/5G 相比(OR=1.80,95%CI 1.17-2.76,P=0.007),4G/5G 与 5G/5G 相比(OR=1.40,95%CI 1.07-1.84,P=0.02),4G 与 5G 相比(OR=1.35,95%CI 1.08-1.68,P=0.008)。

结论

这项荟萃分析表明,PAI-1 基因的-675 4G/5G 多态性是哮喘的一个危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/2c154d8cf91a/pone.0034385.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/a430f27b5520/pone.0034385.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/065202bc79e7/pone.0034385.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/2c154d8cf91a/pone.0034385.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/a430f27b5520/pone.0034385.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/065202bc79e7/pone.0034385.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ba/3313978/2c154d8cf91a/pone.0034385.g003.jpg

相似文献

1
The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.纤溶酶原激活物抑制剂-1 基因-675 4G/5G 多态性与哮喘风险相关:一项荟萃分析。
PLoS One. 2012;7(3):e34385. doi: 10.1371/journal.pone.0034385. Epub 2012 Mar 27.
2
Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.纤溶酶原激活物抑制剂-1 4G/5G多态性与股骨头坏死易感性相关:一项系统评价和Meta分析的证据
Arch Bone Jt Surg. 2018 Nov;6(6):468-477.
3
The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.纤溶酶原激活物抑制剂-1(PAI-1)基因-675位点4G/5G多态性可能与多囊卵巢综合征(PCOS)风险无关。
Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2326-31.
4
Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.纤溶酶原激活物抑制剂-1-675 4G/5G 多态性与脓毒症的关系:荟萃分析。
PLoS One. 2013;8(1):e54883. doi: 10.1371/journal.pone.0054883. Epub 2013 Jan 30.
5
Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.纤溶酶原激活物抑制剂-1 4G/5G多态性与静脉血栓栓塞风险的关联:一项荟萃分析。
Thromb Res. 2014 Dec;134(6):1241-8. doi: 10.1016/j.thromres.2014.09.035. Epub 2014 Oct 5.
6
Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G 多态性与阿尔茨海默病、代谢综合征和女性不孕风险的关联:一项荟萃分析。
Medicine (Baltimore). 2020 Dec 11;99(50):e23660. doi: 10.1097/MD.0000000000023660.
7
Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.纤溶酶原激活物抑制剂-1 4G/5G多态性与糖尿病肾病的关联:中国人群的一项荟萃分析。
Int Urol Nephrol. 2016 Sep;48(9):1483-9. doi: 10.1007/s11255-016-1333-9. Epub 2016 Jun 6.
8
Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.丝氨酸蛋白酶抑制剂 E1(PAI-1)4G/5G 插入/缺失启动子多态性(rs1799889)与子痫前期的关联:系统评价和荟萃分析。
Mol Hum Reprod. 2013 Mar;19(3):136-43. doi: 10.1093/molehr/gas056. Epub 2012 Nov 23.
9
Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis.纤溶酶原激活物抑制剂-1(PAI-1)基因 4G/5G 多态性与白种人群突发性聋的关系:一项荟萃分析。
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2203-2208. doi: 10.1007/s00405-020-06305-z. Epub 2020 Sep 8.
10
PAI-1 Gene Polymorphism Was Associated with an Increased Risk of Allergic Diseases: Evidence from a Meta-Analysis of 14 Case-Control Studies.PAI-1 基因多态性与过敏性疾病风险增加相关:来自 14 项病例对照研究的荟萃分析证据。
Int Arch Allergy Immunol. 2019;180(4):255-263. doi: 10.1159/000502522. Epub 2019 Oct 1.

引用本文的文献

1
The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough.纤溶酶原激活物抑制剂1的4G/5G多态性是过敏性咳嗽的一个预测指标。
Front Genet. 2023 Feb 24;14:1139813. doi: 10.3389/fgene.2023.1139813. eCollection 2023.
2
The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.丝氨酸蛋白酶抑制剂超家族及其在 COPD 和其他慢性肺部疾病中对丝氨酸蛋白酶活性的调节和功能障碍的作用。
Int J Mol Sci. 2021 Jun 14;22(12):6351. doi: 10.3390/ijms22126351.
3
A meta-analysis of the association of the ACE I/D and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Iranian women: Are the investigations adequate?

本文引用的文献

1
Allergic asthma: influence of genetic and environmental factors.过敏性哮喘:遗传和环境因素的影响。
J Biol Chem. 2011 Sep 23;286(38):32883-9. doi: 10.1074/jbc.R110.197046. Epub 2011 Jul 28.
2
SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response.丝氨酸蛋白酶抑制剂 1-675 4G/5G 多态性与哮喘严重程度和吸入皮质类固醇反应有关。
Eur Respir J. 2011 Nov;38(5):1036-43. doi: 10.1183/09031936.00182410. Epub 2011 Apr 8.
3
Recent advances in the pathophysiology of asthma.哮喘病理生理学的最新进展。
伊朗女性中血管紧张素转换酶插入/缺失(ACE I/D)和纤溶酶原激活物抑制剂-1 4G/5G多态性与复发性流产相关性的荟萃分析:研究是否充分?
Turk J Obstet Gynecol. 2021 Jun 2;18(2):139-150. doi: 10.4274/tjod.galenos.2021.58997.
4
Elevated Expression of Plasminogen Activator Inhibitor (PAI-1/SERPINE1) is Independent from rs1799889 Genotypes in Arthrofibrosis.纤溶酶原激活物抑制剂(PAI-1/SERPINE1)的高表达在关节纤维化中与rs1799889基因型无关。
Meta Gene. 2021 Jun;28. doi: 10.1016/j.mgene.2021.100877. Epub 2021 Mar 5.
5
The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype.纤溶酶原激活物抑制剂-1基因4g/5g多态性的作用及生物标志物在变应性和非变应性哮喘表型中的诊断价值
Acta Clin Croat. 2018 Mar;57(1):96-102. doi: 10.20471/acc.2018.57.01.11.
6
Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.纤溶酶原激活物抑制剂1基因4G/5G多态性作为哮喘患者发生过敏性鼻炎症状的危险因素。
Eur Arch Otorhinolaryngol. 2017 Jun;274(6):2613-2619. doi: 10.1007/s00405-017-4502-2. Epub 2017 Mar 3.
7
SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.中国汉族人群中SERPINE1基因-844和-675多态性与慢性阻塞性肺疾病的关系
J Int Med Res. 2016 Dec;44(6):1292-1301. doi: 10.1177/0300060516664270. Epub 2016 Nov 18.
8
Association of a PAI-1 Gene Polymorphism and Early Life Infections with Asthma Risk, Exacerbations, and Reduced Lung Function.纤溶酶原激活物抑制剂-1(PAI-1)基因多态性及早期感染与哮喘风险、病情加重和肺功能降低的关联
PLoS One. 2016 Aug 24;11(8):e0157848. doi: 10.1371/journal.pone.0157848. eCollection 2016.
9
TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.转化生长因子-β1诱导的纤溶酶原激活物抑制因子-1促成嗜酸性食管炎患者的促纤维化网络。
J Allergy Clin Immunol. 2016 Sep;138(3):791-800.e4. doi: 10.1016/j.jaci.2016.02.028. Epub 2016 Apr 8.
10
Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma.纤溶酶原激活物抑制剂口服有效小分子抑制剂对哮喘的治疗潜力
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 15;310(4):L328-36. doi: 10.1152/ajplung.00217.2015. Epub 2015 Dec 23.
Chest. 2010 Jun;137(6):1417-26. doi: 10.1378/chest.09-1895.
4
Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.土耳其成年哮喘患者中纤溶酶原激活物抑制剂-1基因4G/5G多态性
Genet Test Mol Biomarkers. 2009 Aug;13(4):543-6. doi: 10.1089/gtmb.2009.0036.
5
Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.纤溶酶原激活物抑制剂-1与哮喘:在发病机制及分子调控中的作用
Clin Exp Allergy. 2009 Aug;39(8):1136-44. doi: 10.1111/j.1365-2222.2009.03272.x. Epub 2009 May 5.
6
Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.土耳其哮喘和过敏性鼻炎儿童纤溶酶原激活物抑制剂-1基因4G/5G多态性
Allergy Asthma Proc. 2009 Jan-Feb;30(1):41-6. doi: 10.2500/aap.2009.30.3183. Epub 2008 Dec 6.
7
Analysis of -675 4 g/5 G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients.屋尘螨过敏性哮喘患者中SERPINE1基因-675 4G/5G多态性和CD14基因C-159T多态性的分析
J Investig Allergol Clin Immunol. 2008;18(4):284-92.
8
Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during allergen challenge.变应原激发试验期间过敏性哮喘患者血浆纤溶酶原激活物抑制剂-1的浓度
Int Arch Allergy Immunol. 2007;144(3):240-6. doi: 10.1159/000103998. Epub 2007 Jun 19.
9
Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.FCER1B和PAI - 1基因多态性与哮喘易感性
Clin Exp Allergy. 2006 Jul;36(7):872-6. doi: 10.1111/j.1365-2222.2006.02413.x.
10
Gene by environment interaction in asthma.哮喘中的基因与环境相互作用
Curr Allergy Asthma Rep. 2006 Mar;6(2):103-11. doi: 10.1007/s11882-006-0047-y.